PATENT CLAIM ANALYSIS

Application Number: 16081902
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "064000"]

Abstract:
Compounds, pharmaceutical formulations, and methods of treating bacterial infections are disclosed.

Claim (Index 9):
The compound of  claim 8 , or a salt or a hydrate or a solvate thereof, which is (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-hydroxy-1H-benzo[d][1,2,6]oxazaborinin-7-yl)oxy)acetate.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16081904', '16072278', '12306137', '14576718', '10422401']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7471148695475017
- 35 USC 102 Novelty (BERT): 0.5757853001513632
- Combined Prediction Score: 0.7299819126078879
- Mean Citation Score: 275.613584
- Max Citation Score: 475.27502
- Similarity Product: 358.951872905799

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test